Skip to main content
Apply to the COVID-19 Vaccine Counter Misinformation Open Fund by Jan 31.
Pelajari lebih lanjut

What is the COVID-19 Vaccine Counter-Misinformation Open Fund?

The uncertainty and developing nature of the health crisis provoked by the novel coronavirus has made providing accurate, evidence-based journalism more essential than ever.

The COVID-19 Vaccine Counter-Misinformation Open Fund is aimed at supporting journalistic efforts to fact-check misinformation about the COVID-19 immunization process that specifically seek to support audiences that are underserved by fact-checking or targeted by misinformation.

The Fund will make up to USD $3,000,000 available for projects which demonstrate a clear potential to provide effective corrective tools and content to counterbalance COVID-19 vaccine misinformation. Google will fund selected projects up to USD $1,000,000 each, covering up to 80% of the total overall budget of the project. Applicants cannot ask for an amount higher than 50% of their annual total income (Please note, this should reflect the combined annual income of partners for collaborative projects and include revenue generated as well as donations, philanthropy support etc).

Priority will be given to collaborative projects (e.g. multiple news organizations / entities working together) and that are interdisciplinary in nature (e.g. involve journalists working alongside epidemiologists or immunologists).

Important Notice: The COVID-19 Vaccine Counter-Misinformation Open Fund provides funding to journalistic efforts, and is not intended to support creation of medical or health related information. If an applicant creates medical or health related information (including information about misinformation) through projects funded by the COVID-19 Vaccine Counter-Misinformation Open Fund, that information is the sole responsibility of the applicant and its team, and Google will not be responsible for that information.

Apply

Application Process

The application window opens on January 12th, 2021 at 6:00 PT and closes on January 31, 2021 at 23:59 PT. You will be asked to provide descriptions, detailed project plans and budget information via our online application form. You will also have to accept the Terms and Conditions.

Application Eligibility Requirements

The COVID-19 Vaccine Counter-Misinformation Open Fund is open to news organizations of every size, both for profit and nonprofit, publishing on any medium (digital, print, video, etc) that aim to produce original journalistic content. Applicants can be individual organizations or coalitions of publishers, both formal and informal.

All applicants should have a proven track record in fact-checking and debunking activities or partner with an organisation with such recognition. Evidence that third parties recognize the organization as a fact-checker will be required in the application, with membership of the International Fact-Checking Network (IFCN) being the most prominent.

Projects must be ready to launch as soon as possible and no later than April 15, 2021. They should be fully realized within 12 months of obtaining the funding.

Wilayah yang Memenuhi Syarat Menerima Bantuan

Applicants must be incorporated in one of the eligible countries listed below.

Eligible Geographies are (in alphabetical order):

  • Asia Pacific
    Australia, Bangladesh, Bhutan, Brunei, Cambodia, Cook Islands, East Timor, Easter Island, Fiji, Hong Kong SAR, India, Indonesia, Japan, Laos, Macau SAR, Malaysia, Maldives, Mongolia, Myanmar, Nepal, New Caledonia, New Zealand, Pakistan, Papua New Guinea, Philippines, Samoa, Singapore, Solomon Islands, South Korea, Sri Lanka, Taiwan, Thailand, Tokelau, Tonga, Tuvalu, Vanuatu, Vietnam

  • Europe
    Albania, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom

  • Middle East and Africa
    Algeria, Angola, Bahrain, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo (Brazzaville), Democratic Republic of Congo (DRC), Djibouti, Egypt, Equatorial Guinea, Eritrea, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Guinea-Bissau, Iraq, Israel, Ivory Coast, Jordan, KSA, Kenya, Kuwait, Lesotho, Libya, Lebanon, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Palestine, Oman, Qatar, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, South Sudan, Swaziland, Tanzania, Togo, Tunisia, Turkey, Uganda, UAE, Western Sahara, Zambia, Zimbabwe

  • North America
    Canada, United States, United States Overseas Territories

  • Latin America and the Caribbean
    Antigua and Barbuda, Argentina, The Bahamas, Barbados, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominica, Dominican Republic, Ecuador, El Salvador, Grenada, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Uruguay

Eligible Projects

Projects must set out to detect, debunk and effectively countenance misinformation about the COVID-19 immunization process. Successful projects will show that they can serve a broad audience with effective corrective content about COVID-19 vaccine misinformation. The core output of any project will be accurate, timely and accessible fact checks of harmful false claims about COVID-19 immunization. Projects must aim to reach a far broader (or different) audience than would otherwise be reached. This might mean exponentially growing the audience of an existing fact-checking project, or developing new formats for corrective content, or tracking fact checks against their related misinformation to understand how those reached by both respond to the conflicting pieces of information.

Experimental projects are welcome but must be measurable with well-defined goals.

Find below examples of eligible projects. Note that these are for inspiration only and ideas that perfectly match the bullets below may well be rejected:

  • A partnership between an established fact-checking project and a media outlet with deep roots in a specific community that has been underserved by fact checks or targeted by misinformation about COVID-19

  • A data visualization of common misperceptions and their related fact checks and associated primary evidence

  • A searchable database of fact checks about vaccine misinformation

  • A tool to help journalists spot harmful misinformation about the COVID-19 immunization process more efficiently

  • A new format aimed at making fact checks about COVID-19 immunization clearer and more effective at allaying concerns about the vaccine -- especially with audiences that are explicitly targeted by misinformation

  • An analytics tool that assesses not just whether people have read a fact check but also their prior and posterior beliefs about the debunked misinformation

  • A campaign with public health officials to disseminate debunks in doctors’ offices and hospitals

  • A tip line for doctors administering the vaccine to flag to fact-checkers myths they are hearing from their patients -- and an easy mechanism to distribute material that addresses those concerns

  • A collaborative platform for journalists and doctors to jointly publish fact checks

Projects will be evaluated against seven main criteria.

  1. Impact assessment framework:The project has presented a clear methodology of how it will assess the effect of the fact checks it publishes. Specifically, are fact checks clarifying misconceptions that readers had rather than re-affirming something they already knew? How is the fact check affecting the reach of the related misinformation? How is the impact different to what would have been possible without funding? The framework must have both qualitative and quantitative elements.

  2. Expected reach:The project is specific about the reach it expects to have and how it plans to get to those audience figures.

  3. Underserved audiences strategy:The project is clear about how it intends to reach audiences that are typically underserved by fact checks or disproportionately affected by misinformation.

  4. Expertise:The project has a proven track record in fact-checking / debunking and includes public health / immunization experts.

  5. Collaboration:The project is more likely to be considered for funding if it is interdisciplinary in nature (e.g. involve journalists working alongside epidemiologists or immunologists) and if a collaborative approach is taken (e.g. multiple news organizations / entities working together).

  6. Innovation:The project introduces a new format, methodology, structure or distribution mechanism that has never or rarely ever been attempted before at this scale.

  7. Feasibility and urgency:The project can start almost immediately so as to reach audiences around the world while they are directly affected by the COVID-19 immunization process and related misinformation.

Examples of projects that would not qualify:

  • A project that aims to publish explainers about the COVID-19 vaccine and the immunization process without tackling misinformation directly.

  • An existing debunking project that will use the funding to either exclusively cover existing or incremental staffing costs, or exclusively to grow its social media reach through paid ads.

  • A project that plans to publish fact checks but has no team member with a track record of doing so. We encourage projects without prior experience that are eager to apply to seek a partner publisher with background in fact-checking, starting from verified signatories of the IFCN.

  • A project that aims to collect data about COVID-19 misinformation and the effect of fact-checking for the primary purpose of publishing an academic paper. Research can be a component of eligible projects but not its primary goal.

  • A project that is not predominantly about COVID-19 immunization misinformation.

  • Projects that do not include in their team an individual or organization that has ever published a fact check or article debunking misinformation are not eligible.

  • Projects that are run by a government institution are not eligible to apply. Public health experts with ties to government institutions can be part of the project team but not the lead applicants.

  • Academic projects whose sole goal is to conduct and publish research about anti-vaccine misinformation are not eligible.

  • Projects with ties to producers of COVID-19 vaccines are also ineligible.

Project Funding

Google will fund up to $1,000,000 per selected project. Special discretion on the total project cap may be considered by the jury depending on the scale and impact of a very large collaborative application. Google will finance up to 80% of the overall costs of the selected projects. Organizations are expected to detail costs for their projects, which can include in-kind expenditure (for example, people assigned to the project). Eligible expenses include engineering and operations costs (e.g. product development, project management, user experience design, database build and maintenance, and hosting), the purchase or licensing of any equipment, tools, hardware, software and other assets or materials needed for the project and marketing expenses (capped to 20% of the total amount requested). Funding may not be spent on general and overhead costs. Please note that the effective date for the project will be the date that the funding agreement is signed. No expenses incurred before this date can be covered by the funding.

Governance

Applications to the COVID-19 Vaccine Counter-Misinformation Open Fund are reviewed by a combination of the Google Project Team and the Jury. The Project Team will review all applications and interview applicants and then make a recommendation on funding projects. The Project Team is composed of Google employees working on News product, partnerships, UXR as well as public policy, research and trust & safety. These include:

Alexios Mantzarlis, Ashley Edwards, Clement Wolf, David Sklar, Harris Cohen, Irene Jay Liu, Isabelle Sonnenfeld, Lisa Lehman, Sarah Hartley, Simon Baumgartner, Sven Naumann, Vincent Ryan

The Jury will select the Open Fund winners and is composed by the following individuals:

Alexios Mantzarlis, News and Information Credibility Lead, Google News Lab
Alexios works on product and partnership efforts to counter misinformation, particularly around fact-checking and news credibility signals. He has led efforts to highlight fact checks to users in product, share information on their reach and support the fact-checking ecosystem’s response to the COVID-19 infodemic. Prior to joining Google, Alexios served as the founding director of the International Fact-Checking Network, where he helped draft the fact-checkers' code of principles and shepherd a seminal partnership between fact-checkers and Facebook. His work has been published on the American Journal of Health Education and Political Quarterly.

Amy Pisani, Executive Director, Vaccinate Your Family
Amy Pisani is a leading authority in vaccine advocacy. As the long-time executive director of the nonprofit organization Vaccinate Your Family, Pisani is a leader in building alliances with like-minded interests, working with the media to ensure science-based reporting on vaccines, and educating the public in person and online. With a total of 200,000+ followers across Facebook, Twitter, Instagram, and YouTube, VYF has a substantial social media presence, reaching over 3.2 million people annually with science-based information about the importance of timely vaccinations and the safety of vaccines for people of all ages.

Angela Pimenta, Director of operations, Projor
Angela Pimenta is a co-coordinator of the Brazilian chapter of the Trust Project. She holds a Masters in Journalism from Columbia University and is a candidate at the Media and Technology PhD program of São Paulo State University (Unesp). Her doctoral research investigates media literacy strategies for the out-of-school Brazilian population.

Andy Pattison, Team Lead, Digital Channels, World Health Organization
Over the last 25 years, Andy has held a range of leadership roles in the digital space, supporting innovation across both private and public sectors. At WHO, Andy strives to amplify vital public health messages to more people through more channels. During the COVID-19 emergency, Andy has engaged the digital sector to support this mission and leads the Tech Task Force, a conglomerate of over 50 companies working to tackle misinformation, raise quality content and develop new digital channels. Through his work, WHO has been able to reach billions of people. Andy has also been the web lead for over 35 emergencies while at WHO, with deployments to the African Region to support both Ebola and Cholera outbreaks.

Baybars Örsek, Director, International Fact-Checking Network
Baybars Örsek is the director of the International Fact-Checking Network (IFCN) at The Poynter Institute, the premier global coalition of fact-checking organizations. Prior to joining IFCN, Örsek had served as the founding executive director of the Turkish fact-checking organization Doğruluk Payı between 2014 and 2019. He is a frequent expert source for major media outlets around the world. Örsek is a member of the board of trustees at TESEV, Turkey’s oldest think tank. Before launching Doğruluk Payı in 2014, he worked at his alma mater Istanbul Bilgi University. Örsek holds a B.A. degree in international relations and an M.A. degree in conflict resolution.

Gagandeep Kang, Professor of Microbiology, Christian Medical College (CMC) in Vellore
Gagandeep Kang is the first woman from India to be elected a Fellow of the Royal Society. She received her training in medicine and microbiology at the Christian Medical College, Vellore and post-doctoral training in the UK and US before returning to India to continue her work on enteric infections in children. With Indian and global collaborators, she has worked on the development and use of vaccines for rotaviruses, cholera and typhoid, conducting large studies to define burden, test vaccines and measure their impact.

Ifeoma Ozoma, Founder and Principal, Earthseed
Ifeoma Ozoma is the Founder and Principal of Earthseed. She is a tech policy expert with experience leading global public policy partnerships, public policy related content safety development, and US Federal, State, and International policymaker engagement at Pinterest, Facebook, and Google. Ifeoma’s health misinformation initiatives have been lauded by the World Health Organization, the Washington Post’s Editorial Board, and the New York Times. Ifeoma is also on the First Draft Inc, Board of Directors, a member of the Brookings Institution’s Transatlantic Working Group on Disinformation, and a member of The Washington Post's Technology 202 Network.

Ludovic Blecher, Head, Google News Initiative Innovation
Before joining Google, Ludovic Blecher was the director of the FINP: a digital press fund for French publishers backed by Google. During his first 3 years at Google he led our effort to stimulate the european news-ecosystem as the Head of the Digital News Innovation Fund. Ludovic is a journalist who has spent the past 15 years working in news. His career began as a reporter at Liberation, rising to Editor in Chief then Chief digital officer. He's a 2012 fellow at the Nieman Foundation for Journalism at Harvard, and was a member of the French Digital Council independent advisory commission for the French Government.

Renee DiResta, Technical Research Manager, Stanford Internet Observer
Renée DiResta is the Technical Research Manager at the Stanford Internet Observatory, a cross-disciplinary program of research, teaching and policy engagement for the study of abuse in current information technologies. Renee investigates the spread of malign narratives and propaganda across social and media networks. Her work examines the ways in which different actors leverage the information ecosystem to exert influence, from domestic activists promoting health misinformation and conspiracy theories, to well-resourced full-spectrum information operations executed by state-sponsored actors.

Susannah Eliott, CEO, Australian Science Media Centre
Susannah Eliott has a PhD in cell biology, a postgraduate diploma in journalism and an honorary doctorate in science communication. She has worked at the coal face between science and the media in Australia and internationally for more than 25 years. She currently leads the Australian Science Media Centre, a not-for-profit organisation dedicated to promoting evidence in media reporting.

Syed Nazakat, Founder & CEO, Data Leads
Syed Nazakat is an award-winning Indian journalist, media entrepreneur, founder of DataLEADS. He leads DataLEADS in New Delhi, as well as oversees its outreach across Asia with different partners. He has worked in senior positions at different media organisations, reported from over 30 countries and his work has earned him global recognition and awards. Also as a Program Director, he leads the GNI India Training Network which is a fact-checking training effort for journalists and newsrooms that resulted in the launch of many fact-checking initiatives in India, in multiple languages. He is also founder of Health Analytics Asia and First Check –- two dedicated health reporting and fact-checking journalism platforms.

Theresa Amobi, Senior Lecturer, University of Lagos
Dr. Theresa Ifeoma Amobi is a Senior Lecturer at the Department of Mass Communication, University of Lagos, Nigeria. She teaches Multimedia and Online Journalism, Health Communication, Broadcasting and Film, International Communication, Social Science Research and Theories of Communication. Her research interests include Health Mis/Disinformation and Conspiracy theories, Media and Gender, Nollywood Film Industry, among others. She is a member of the Advisory Board of Africa Check, Fullfact and Chequeado; an Independent Researcher for Africa Check and other international agencies; and has been a member of the African Movies Academy Awards AMAA College of Screeners since 2014.

Yamil Velez, Assistant Professor of Political Science, Columbia University
Yamil Velez is a political scientist at Columbia University. His work focuses on how demographic change is shaping American politics. He is currently working on several projects related to Latino media, identity, and political attitudes. His research has been published in leading journals such as the Journal of Politics, American Journal of Political Science, and Political Behavior.

Brian Yau, Promotion & Engagement Lead, Vaccine Safety Net at WHO
Brian is an infodemic manager and creative design thinker with a background in product design engineering. He joined the Vaccine Safety Net (VSN) to develop partnerships, seek external collaborators, and explore digital innovations to further vaccine safety communication online. Established by the World Health Organization, the VSN is a network of 94 organizations, promoting reliable sources of information on vaccine safety.

FAQ

Siapa yang berhak mendaftar? Jawaban

The COVID-19 Vaccine Counter-Misinformation Open Fund is open to news organizations of every size, both for profit and nonprofit, on any medium (digital, print, video, etc) that aim to produce original journalistic content. Applicants can be individual organizations or coalitions of publishers, both formal and informal.

All applicants should have a proven track record in fact checking and debunking activities or partner with an organisation with such recognition. Evidence that third parties recognize the organization as a fact-checker will be required in the application, with membership of the International Fact-Checking Network (IFCN) being the most prominent. See the next question for more details.

Applicant's project teams should demonstrate (a) a track record of publishing fact checks or other types of journalistic work aimed at correcting misperceptions about topics of public concern (b) the capacity of any public health experts included in the project to provide appropriate expertise on COVID-19 immunization (c) a sound understanding of the limitations of fact-checking a contested topic and (d) a clear framework to maximize the impact of fact checks among their audience.

Projects must be ready to launch as soon as possible and no later than April 15. They should be fully realized within 12 months of obtaining the funding.

What is a “fact-checking or debunking organization”? Jawaban

We will follow the IFCN definition of a fact-checking project: “organizations that regularly publish nonpartisan reports on the accuracy of statements by public figures, major institutions, and other widely circulated claims of interest to society.” Being a verified signatory of the IFCN is a positive signal but not a necessary condition for applicants.

We will expect evidence that reputable third-parties recognize your organization as a fact-checking project or an organization that supports journalists who debunk misinformation. This includes media mentions, institutional partnerships, platform collaborations, and so on.

How are projects evaluated? Jawaban

Projects will be evaluated against seven main criteria.

  1. Impact assessment framework: The project has presented a clear methodology of how it will assess the effect of the fact check it publishes. Specifically, are fact checks clarifying misconceptions that readers had rather than re-affirming something they already knew? How is the fact check affecting the reach of the related misinformation? How is the impact different to what would have been possible without funding? The framework must have both qualitative and quantitative elements.

  2. Expected reach: The project is specific about the reach it expects to have and how it plans to get to those audience figures.

  3. Underserved audiences strategy: The project is clear about how it intends to reach audiences that are typically underserved by fact checks or disproportionately affected by misinformation.

  4. Expertise: The project has a proven track record in fact-checking / debunking and includes public health / immunization experts.

  5. Collaboration: The project is more likely to be considered for funding if it is interdisciplinary in nature (e.g. involve journalists working alongside epidemiologists or immunologists) and if a collaborative approach is taken (e.g. multiple news organizations / entities working together).

  6. Innovation: The project introduces a new format, methodology, structure or distribution mechanism that has never or rarely ever been attempted before at this scale.

  7. Feasibility and urgency: The project can start almost immediately so as to reach audiences around the world while they are directly affected by the COVID-19 immunization process and related misinformation.

Bagaimana cara kerja proses seleksi? Jawaban

Initial selection of projects will be done by a Project Team, composed of a diverse team of Google staff who have knowledge and/or experience in healthcare and journalism. They will review all applications for eligibility, innovation and impact. They’ll compose a shortlist, conduct interviews with applicants and make recommendations to the Covid Vaccine Debunking Open Fund Jury.

Kapan saya bisa mendaftar? Jawaban

The application window opens on January 12th, 2021 at 6:00 PT and closes on January 31, 2021 at 23:59 PT.

Bagaimana saya bisa mendaftar? Jawaban

We will consider applications written in English only. You will be asked to provide descriptions, detailed project plans and budget information in our online application form as well as accept the COVID-19 Vaccine Counter-Misinformation Open Fund Application Terms and Conditions. See the application forms here.

How can I best prepare my submission? Jawaban

Take advantage of the application window to document your project as thoroughly as possible.

Please take the time to consult with project team members and study the research on fact-checking, misinformation and vaccine conspiracy theories. Your team will have to prepare an explicit impact assessment framework (see Selection Criteria) so make sure you have a clear understanding of what you hope to achieve before you start your application.

When you are ready, please go to the online form and submit the application. If you need additional information, please contact us at vcmfund@google.com.

Informasi apa yang dibutuhkan untuk permohonan saya? Jawaban

In order to assess the projects, the Project Team will need information including:

  1. Company/individual information
  2. Location, URL, number of employees, number of journalists
  3. Project description
  4. Project budget and amount of funding requested
  5. Key indicators to measure the impact of the project
  6. A slideshow of 10 slides or fewer which should address at least the following:
    1. Project team (including relevant expertise)
    2. Description of challenge project is addressing
    3. Project description
    4. Project innovation
    5. Impact framework
    6. Underserved audience strategy (see selection criteria)
    7. Timeline

As set out in the COVID-19 Vaccine Counter-Misinformation Open Fund Terms & Conditions, we require that applicants do not submit any Business Sensitive Information (as defined in the Application Terms and Conditions). Google intends to publicise its activities relating to the COVID-19 Vaccine Counter-Misinformation Open Fund. As outlined in the Application Terms and Conditions, it is a condition of application that Google may publicise aggregated data showing how funds have been offered in the COVID-19 Vaccine Counter-Misinformation Open Fund and certain project-specific information.

What if I want to work in collaboration with others? Jawaban

Collaborative applications with other industry players are very welcome. You can find more information on how to make a collaborative application in the COVID-19 Vaccine Counter-Misinformation Open Fund Terms & Conditions.

How much funding should I apply for? Jawaban

Google will fund selected projects up to $1M each, covering up to 80% of the total overall budget of the project. Applicants cannot ask for an amount higher than 50% of their annual total income (Please note, this should reflect the combined annual income of partners for collaborative projects and include revenue generated as well as donations, philanthropy support etc). The overall budget should be consistent depending on what you’re trying to achieve as well as the size of your organization. Projects of any size will be considered and our strong recommendation is to provide a total budget which is reasonable and proportionate to the project. The jury might decide to lower or increase the amount of funding provided and special discretion on the total project cap may be considered by the jury depending on the scale and impact of a very large collaborative effort. Payments will be done in two installments over the course of this year based on clear milestones.

Di mana saya dapat membaca salinan lengkap syarat dan ketentuan? Jawaban

You can find the COVID-19 Vaccine Counter-Misinformation Open Fund Terms & Conditions here.

Apakah setiap aplikasi akan ditinjau? Jawaban

Yes, we will review all eligible applications received by the application deadline.

How can I contact the GNI Project Team? Jawaban

If you would like to contact the team please email vcmfund@google.com.

During the assessment process, applicants may be asked to provide additional details about their project, including through interviews and/or the submission of further supporting documents.

Berapa banyak permohonan yang dapat saya kirim? Jawaban

Each applicant may only submit one application as a lead applicant but can be a partner to as many unique projects as they want. Organizations that are part of a larger group or holding structure can submit up to 3 project applications per group or holding.

Apa yang akan Anda lakukan dengan informasi yang saya kirimkan? Jawaban

A limited number of people from the Project Team and Jury will have access to the responses that applicants provide. They will use the responses to assess the projects.

Application information received by Project Team and Jury will be exclusively used for Covide Vaccine Debunking Open Fund operations and processes. Google will only share detailed application information outside the Project Team and Jury with the applicant's permission. Additionally, as described in the Application Terms and Conditions, certain information may be used by Google for publicity purposes.

Please see the Application Terms and Conditions for further detail on how we will treat information that you provide to us. As set out in the Application Terms and Conditions, we require that applicants do not submit to us any Business Sensitive Information (as defined in the Application Terms and Conditions). If the applicant has indicated that they wish to be connected to other applicants or industry groups, the Project Team may contact the applicant to offer knowledge sharing opportunities (featuring projects at events, case studies, etc).

Are there spending limitations? Jawaban

Funding may not be spent on: General and overhead costs such as office rental, furniture and travel expenses, costs and expenses connected with registering, protecting, defending or monetising any intellectual property rights you may have (or that you may obtain through registration). This includes payments to any personnel engaged in such activities, or expenses or liabilities incurred before the date on which the parties enter into a Funding Agreement.

Which expenses are eligible? Jawaban

Eligible expenses include engineering and operations costs (e.g. product development, project management, user experience design, database build and maintenance, and hosting) and marketing expenses. Please note marketing expenses will only be covered up to 20% of the total funding offered.

Please note that the effective date for the project will be the date that we sign the funding agreement. No expenses incurred before this date can be covered by the funding.

Apa saja yang termasuk informasi sensitif? Jawaban

Business Sensitive Information is confidential information which, if disclosed, would provide your competitors with a competitive advantage over you or would otherwise cause substantial harm to you.

Please see the Application Terms and Conditions for further information on this.

As the owner of your project, you are the best judge on what information is Business Sensitive. However, if you are in any doubt about this then we recommend that you seek independent legal advice.

Kapan saya akan dikabari mengenai permohonan saya? Jawaban

If your application is shortlisted, you will hear from us about one month after the closure of the application window with any follow up questions we have before communicating our final decision to selected applicants. At that time we will contact you by email and arrange a video meeting to discuss the funding process in greater detail. Unsuccessful applications will be notified, but we can’t provide specific feedback to applicants who have not been selected.

If the project is not selected, can I learn more about why? Jawaban

Unfortunately, due to the high volume of applications expected, the Project Team is unable to provide personalised feedback on each proposal. That said, we will make ourselves available for general advice in the future and to answer questions about the application process. The email for contact is vcmfund@google.com.

What is the role of the Project Team? Jawaban

Initial selection of projects will be done by a Project Team, composed of Google staff with experience in journalism and misinformation. They will review all applications for eligibility, innovation and impact, pre-select projects and make recommendations for final selection to the Fund's Jury.

What is the role of The Jury? Jawaban

Fund oversight and final approval will be decided by a jury composed of Google staff and experts on misinformation, immunization, or both. The jury team will receive and review a list of shortlisted projects and will vote for the final selection based on the project's team recommendations.

Who is part of the Project Team? Jawaban

The project team will consist of internal stakeholders responsible for ensuring and communicating the success of the COVID-19 Vaccine Counter-Misinformation Open Fund. The Project Team is composed of Google employees working on News product, partnerships, UXR as well as public policy, research and trust & safety. These include:

Alexios Mantzarlis, Ashley Edwards, Clement Wolf, David Sklar, Harris Cohen, Irene Jay Liu, Isabelle Sonnenfeld, Lisa Lehman, Sarah Hartley, Simon Baumgartner, Sven Naumann, Vincent Ryan

Who is part of the jury? Jawaban

The jury is composed by the following individuals:

Alexios Mantzarlis, News and Information Credibility Lead, Google News Lab
Alexios works on product and partnership efforts to counter misinformation, particularly around fact-checking and news credibility signals. He has led efforts to highlight fact checks to users in product, share information on their reach and support the fact-checking ecosystem’s response to the COVID-19 infodemic. Prior to joining Google, Alexios served as the founding director of the International Fact-Checking Network, where he helped draft the fact-checkers' code of principles and shepherd a seminal partnership between fact-checkers and Facebook. His work has been published on the American Journal of Health Education and Political Quarterly.

Amy Pisani, Executive Director, Vaccinate Your Family
Amy Pisani is a leading authority in vaccine advocacy. As the long-time executive director of the nonprofit organization Vaccinate Your Family, Pisani is a leader in building alliances with like-minded interests, working with the media to ensure science-based reporting on vaccines, and educating the public in person and online. With a total of 200,000+ followers across Facebook, Twitter, Instagram, and YouTube, VYF has a substantial social media presence, reaching over 3.2 million people annually with science-based information about the importance of timely vaccinations and the safety of vaccines for people of all ages.

Angela Pimenta, Director of operations, Projor
Angela Pimenta is a co-coordinator of the Brazilian chapter of the Trust Project. She holds a Masters in Journalism from Columbia University and is a candidate at the Media and Technology PhD program of São Paulo State University (Unesp). Her doctoral research investigates media literacy strategies for the out-of-school Brazilian population.

Andy Pattison, Team Lead, Digital Channels, World Health Organization
Over the last 25 years, Andy has held a range of leadership roles in the digital space, supporting innovation across both private and public sectors. At WHO, Andy strives to amplify vital public health messages to more people through more channels. During the COVID-19 emergency, Andy has engaged the digital sector to support this mission and leads the Tech Task Force, a conglomerate of over 50 companies working to tackle misinformation, raise quality content and develop new digital channels. Through his work, WHO has been able to reach billions of people. Andy has also been the web lead for over 35 emergencies while at WHO, with deployments to the African Region to support both Ebola and Cholera outbreaks.

Baybars Örsek, Director, International Fact-Checking Network
Baybars Örsek is the director of the International Fact-Checking Network (IFCN) at The Poynter Institute, the premier global coalition of fact-checking organizations. Prior to joining IFCN, Örsek had served as the founding executive director of the Turkish fact-checking organization Doğruluk Payı between 2014 and 2019. He is a frequent expert source for major media outlets around the world. Örsek is a member of the board of trustees at TESEV, Turkey’s oldest think tank. Before launching Doğruluk Payı in 2014, he worked at his alma mater Istanbul Bilgi University. Örsek holds a B.A. degree in international relations and an M.A. degree in conflict resolution.

Gagandeep Kang, Professor of Microbiology, Christian Medical College (CMC) in Vellore
Gagandeep Kang is the first woman from India to be elected a Fellow of the Royal Society. She received her training in medicine and microbiology at the Christian Medical College, Vellore and post-doctoral training in the UK and US before returning to India to continue her work on enteric infections in children. With Indian and global collaborators, she has worked on the development and use of vaccines for rotaviruses, cholera and typhoid, conducting large studies to define burden, test vaccines and measure their impact.

Ifeoma Ozoma, Founder and Principal, Earthseed
Ifeoma Ozoma is the Founder and Principal of Earthseed. She is a tech policy expert with experience leading global public policy partnerships, public policy related content safety development, and US Federal, State, and International policymaker engagement at Pinterest, Facebook, and Google. Ifeoma’s health misinformation initiatives have been lauded by the World Health Organization, the Washington Post’s Editorial Board, and the New York Times. Ifeoma is also on the First Draft Inc, Board of Directors, a member of the Brookings Institution’s Transatlantic Working Group on Disinformation, and a member of The Washington Post's Technology 202 Network.

Ludovic Blecher, Head, Google News Initiative Innovation
Before joining Google, Ludovic Blecher was the director of the FINP: a digital press fund for French publishers backed by Google. During his first 3 years at Google he led our effort to stimulate the european news-ecosystem as the Head of the Digital News Innovation Fund. Ludovic is a journalist who has spent the past 15 years working in news. His career began as a reporter at Liberation, rising to Editor in Chief then Chief digital officer. He's a 2012 fellow at the Nieman Foundation for Journalism at Harvard, and was a member of the French Digital Council independent advisory commission for the French Government.

Renee DiResta, Technical Research Manager, Stanford Internet Observer
Renée DiResta is the Technical Research Manager at the Stanford Internet Observatory, a cross-disciplinary program of research, teaching and policy engagement for the study of abuse in current information technologies. Renee investigates the spread of malign narratives and propaganda across social and media networks. Her work examines the ways in which different actors leverage the information ecosystem to exert influence, from domestic activists promoting health misinformation and conspiracy theories, to well-resourced full-spectrum information operations executed by state-sponsored actors.

Susannah Eliott, CEO, Australian Science Media Centre
Susannah Eliott has a PhD in cell biology, a postgraduate diploma in journalism and an honorary doctorate in science communication. She has worked at the coal face between science and the media in Australia and internationally for more than 25 years. She currently leads the Australian Science Media Centre, a not-for-profit organisation dedicated to promoting evidence in media reporting.

Syed Nazakat, Founder & CEO, Data Leads
Syed Nazakat is an award-winning Indian journalist, media entrepreneur, founder of DataLEADS. He leads DataLEADS in New Delhi, as well as oversees its outreach across Asia with different partners. He has worked in senior positions at different media organisations, reported from over 30 countries and his work has earned him global recognition and awards. Also as a Program Director, he leads the GNI India Training Network which is a fact-checking training effort for journalists and newsrooms that resulted in the launch of many fact-checking initiatives in India, in multiple languages. He is also founder of Health Analytics Asia and First Check –- two dedicated health reporting and fact-checking journalism platforms.

Theresa Amobi, Senior Lecturer, University of Lagos
Dr. Theresa Ifeoma Amobi is a Senior Lecturer at the Department of Mass Communication, University of Lagos, Nigeria. She teaches Multimedia and Online Journalism, Health Communication, Broadcasting and Film, International Communication, Social Science Research and Theories of Communication. Her research interests include Health Mis/Disinformation and Conspiracy theories, Media and Gender, Nollywood Film Industry, among others. She is a member of the Advisory Board of Africa Check, Fullfact and Chequeado; an Independent Researcher for Africa Check and other international agencies; and has been a member of the African Movies Academy Awards AMAA College of Screeners since 2014.

Yamil Velez, Assistant Professor of Political Science, Columbia University
Yamil Velez is a political scientist at Columbia University. His work focuses on how demographic change is shaping American politics. He is currently working on several projects related to Latino media, identity, and political attitudes. His research has been published in leading journals such as the Journal of Politics, American Journal of Political Science, and Political Behavior.

Brian Yau, Promotion & Engagement Lead, Vaccine Safety Net at WHO
Brian is an infodemic manager and creative design thinker with a background in product design engineering. He joined the Vaccine Safety Net (VSN) to develop partnerships, seek external collaborators, and explore digital innovations to further vaccine safety communication online. Established by the World Health Organization, the VSN is a network of 94 organizations, promoting reliable sources of information on vaccine safety.